Apple loses latest bid to thwart patent dispute threatening to stop U.S. sales of two watch models

Apple has been rebuffed in its latest attempt to untangle a patent dispute that is pushing the company into suspending sales of two popular Apple Watch models as the holiday shopping season wraps up. The International Trade Commission rejected Apple's bid to get around a late October order revolving around the technology used in the Blood Oxygen measurement feature on the Series 9 and Ultra 2 versions of its internet-connected watch.